Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$13.8B
sum of reported positions
Reported positions
166
Changes vs prior quarter
199
35 new · 36 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 307 measured positions in 8 quarters, the typical new or larger position finished −1.5 pts against the S&P 500 and 46% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 22.5M | $840M | 6.1% | |
| 4.2M | $660M | 4.8% | |
| 1.17M | $488M | 3.5% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $9.98B | $13.8B |
| Positions | 167 | 166 |
| Biggest line | — | Applied Digital 6% |
| 1.1M |
| $411M |
| 3.0% |
| 1.35M | $407M | 3.0% |
| 2.25M | $364M | 2.6% |
| 1.3M | $266M | 1.9% |
| 1.22M | $264M | 1.9% |
| 663K | $247M | 1.8% |
| 3.06M | $238M | 1.7% |
| 263K | $225M | 1.6% |
| 1.47M | $225M | 1.6% |
| 2.57M | $211M | 1.5% |
| 1.4M | $209M | 1.5% |
| 1.39M | $206M | 1.5% |
| 13.7M | $193M | 1.4% |
| 1.99M | $192M | 1.4% |
| 1.65M | $191M | 1.4% |
| 6.48M | $179M | 1.3% |
| 3.14M | $156M | 1.1% |
| 1.94M | $154M | 1.1% |
| 499K | $149M | 1.1% |
| 11.7M | $148M | 1.1% |
| 6.18M | $147M | 1.1% |
| 2.3M | $145M | 1.1% |
Praxis Precision Medicines (PRAX)
359K → 425K shares (+19%)
PTC Therapeutics, Inc. (PTCT)
1.66M → 1.74M shares (+4%)
Granite Construction, Inc. (GVA)
889K → 871K shares (−2%)
Unity Software (U)
4.49M → 4.74M shares (+5%)
Rush Street Interactive, Inc. (RSI)
3.65M → 4.45M shares (+22%)
Scholar Rock Holding (SRRK)
2.05M → 2.22M shares (+9%)
ACI Worldwide (ACIW)
2.39M → 2.33M shares (−3%)
ESCO Technologies Inc. (ESE)
304K → 330K shares (+9%)
Insmed (INSM)
689K → 1.06M shares (+54%)
Red Cat Holdings (RCAT)
3.03M → 10.6M shares (+249%)
Butterfly Network (BFLY)
8.62M → 13.2M shares (+53%)
Cava Group (CAVA)
1.18M → 1.41M shares (+19%)
Protagonist Therapeutics, Inc. (PTGX)
829K → 883K shares (+6%)
APi Group (APG)
2.35M → 2.54M shares (+8%)
Draftkings (DKNG)
454K → 4.25M shares (+835%)
Life Time Group Holdings, Inc. (LTH)
2.62M → 2.55M shares (−3%)
Bridgebio Pharma (BBIO)
1.27M → 1.35M shares (+7%)
SiTime (SITM)
203K → 134K shares (−34%)
Axsome Therapeutics (AXSM)
372K → 403K shares (+8%)
Ondas (ONDS)
10.3M → 11.7M shares (+14%)
Karman Holdings (KRMN)
1.29M → 1.92M shares (+49%)
TTM Technologies (TTMI)
516K → 502K shares (−3%)
AeroVironment (AVAV)
564K shares
WesBanco (WSBC)
2.01M → 2.37M shares (+18%)
Arrowhead Pharmaceuticals (ARWR)
1.06M → 1.12M shares (+6%)
